|
시장보고서
상품코드
1890938
효소면역측정법 시장 : 제품 유형별, 기술별, 용도별, 검체 유형별, 자동화 레벨별, 최종사용자별, 지역별Enzyme Immunoassay Market, By Product Type, By Technology, By Application, By Specimen Type, By Automation Level, By End User, By Geography |
||||||
효소면역측정법 시장은 2025년에 191억 4,000만 달러로 추정되며, 2032년까지 248억 5,000만 달러에 달할 것으로 예측되고 있습니다. 2025-2032년의 CAGR은 3.8%로 전망되고 있습니다.
| 리포트 내용 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2024년 | 2025년 시장 규모 : | 191억 4,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2025-2032년 |
| 예측 기간인 2025-2032년의 CAGR : | 3.80% | 2032년에서 예측 : | 248억 5,000만 달러 |
세계 효소면역측정법 시장은 광범위한 진단 테스트 산업에서 중요한 부문으로, 면역학적 반응의 특이성과 효소의 촉매 특성을 결합하여 다양한 생물학적 물질의 검출 및 정량화를 실현하고 있습니다. 효소면역측정법(ELISA; 효소 결합 면역 흡착법)은 항체와 항원의 상호작용과 효소 반응을 결합하여 측정 가능한 신호를 생성하고, 임상 검체에서 단백질, 호르몬, 병원체, 기타 바이오마커를 정밀하게 검출할 수 있습니다.
이 기술은 임상 진단, 의약품 조사, 식품안전검사, 환경 모니터링 등 여러 분야에서 필수적인 기술입니다. 시장에는 샌드위치 ELISA, 경쟁 ELISA, 간접 ELISA, 직접 ELISA 등 특정 분석 요구 사항을 충족하도록 설계된 다양한 형식이 있습니다. 질병의 조기발견, 맞춤의료, 현장검사에 대한 관심이 높아지면서 효소면역측정법은 민감도, 특이성, 신속한 결과 제공을 위해 계속 진화하고 있습니다.
시장 역학
세계 효소면역측정법 시장은 주로 당뇨병, 심혈관 질환, 감염성 질환, 암과 같은 만성질환의 유병률 증가에 의해 주도되고 있습니다. 이를 위해서는 전 세계 의료 시스템에서 빈번한 진단 모니터링과 스크리닝 프로그램이 필요합니다. 전 세계 인구의 고령화와 더불어 의료에 대한 인식이 높아지고 예방 의료를 장려하는 정부의 구상은 신뢰할 수 있는 진단 솔루션에 대한 수요를 크게 증가시키고 있습니다. 분석 개발의 기술적 진보, 특히 다중화 플랫폼, 자동화 시스템, POC(Point-Of-Care) 기기의 도입으로 검사 효율이 향상되고 시장 적용 범위가 확대되었습니다. 그러나 진단 기기 승인에 대한 엄격한 규제 요건 등 시장에는 심각한 제약이 존재합니다. 이는 종종 장기적이고 비용이 많이 드는 검증 과정으로 이어져 제품 출시 지연과 개발 비용 증가로 이어집니다.
특히 의료 예산이 한정된 신흥 시장에서 고급 효소면역측정장비(EIA)의 높은 비용과 복잡한 시스템을 조작할 수 있는 숙련된 기술자의 필요성은 추가적인 장벽으로 작용하고 있습니다. 화학발광면역측정법(CLIA), 분자진단, 신속항원검사 등 대체 진단기술과의 경쟁은 가격 압박과 시장 점유율에 대한 과제를 야기하고 있습니다. 그러나 의료 인프라의 개선과 가처분 소득 증가가 진단 서비스 수요를 견인하는 신흥 시장에서의 적용 확대에는 큰 기회가 존재합니다. 맞춤형 의료, 동반진단, 바이오마커 발견에 대한 관심 증가는 시장 성장의 새로운 길을 제시하고 있으며, 인공지능과 디지털 헬스 플랫폼의 통합은 분석 성능과 데이터 관리 능력을 향상시킬 수 있는 잠재력을 가지고 있습니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 예측 기간(2025-2032년)의 연평균 성장률(CAGR)을 제시함으로써 세계의 효소면역측정법 시장에 대한 상세한 분석을 제공합니다.
- 또한 다양한 부문의 잠재적 매출기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 성장 촉진요인, 제약요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서에서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계 효소면역측정법 시장의 주요 기업 개요을 제공합니다.
- 이 보고서는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내리는 데 도움이 될 것입니다.
- 이 세계 효소면역측정법 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 효소 면역측정 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 리포트 개요
- 시장 정의와 범위
- 개요
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수의 동향
- 업계 동향
제4장 세계의 효소면역측정법 시장 : 제품 유형별, 2020-2032년
- 시약 및 키트
- 분석기/기기
- 소프트웨어 및 자동화 시스템
- 소모품 및 부속품
제5장 세계의 효소면역측정법 시장 : 기술별, 2020-2032년
- 효소면역측정법(ELISA)
- 효소 결합 형광법(ELFA)
- 화학 발광효소면역측정법(CL-EIA)
- 신속 검사 효소면역측정법
- 다중 효소면역측정법
제6장 세계의 효소면역측정법 시장 : 용도별, 2020-2032년
- 감염증 진단
- 종양학
- 심장병학
- 자가면역질환
- 내분비학
- 약물 모니터링 및 독성학
- 알레르기 검사
- 기타
제7장 세계의 효소면역측정법 시장 : 검체 유형별, 2020-2032년
- 혈액/혈청
- 뇨
- 타액
- 조직 샘플
- 기타(뇌척수액, 혈장)
제8장 세계의 효소면역측정법 시장 : 자동화 레벨별, 2020-2032년
- 수동
- 반자동
- 완전 자동화
제9장 세계의 효소면역측정법 시장 : 최종사용자별, 2020-2032년
- 병원 및 진료소
- 진단 검사실
- 연구기관 및 학술기관
- 제약·바이오테크놀러지 기업
- 수탁 조사기관(CRO)
제10장 세계의 효소면역측정법 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제11장 경쟁 구도
- Abbott
- Roche Diagnostics
- Siemens Healthineers
- bioMerieux
- Beckman Coulter(Danaher)
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Revvity(PerkinElmer)
- DiaSorin
- QuidelOrtho
- EUROIMMUN(a Revvity company)
- Randox Laboratories
- Bio-Techne(R&D;Systems)
- Merck KGaA(MilliporeSigma)
- Tecan
제12장 애널리스트의 권장사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고 문헌 및 조사 방법
- 참고 문헌
- 조사 방법
- 출판사 소개
Enzyme Immunoassay Market is estimated to be valued at USD 19.14 Bn in 2025 and is expected to reach USD 24.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 19.14 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.80% | 2032 Value Projection: | USD 24.85 Bn |
The global enzyme immunoassay market represents a critical segment within the broader diagnostic testing industry, leveraging the specificity of immunological reactions combined with the catalytic properties of enzymes to detect and quantify various biological substances. Enzyme immunoassays, also known as enzyme-linked immunosorbent assays (ELISA), utilize antibody-antigen interactions coupled with enzymatic reactions to produce measurable signals, enabling precise detection of proteins, hormones, pathogens, and other biomarkers in clinical samples.
This technology has become indispensable across multiple sectors including clinical diagnostics, pharmaceutical research, food safety testing, and environmental monitoring. The market encompasses various formats such as sandwich ELISA, competitive ELISA, indirect ELISA, and direct ELISA, each designed to address specific analytical requirements. With increasing emphasis on early disease detection, personalized medicine, and point-of-care testing, enzyme immunoassays have evolved to offer enhanced sensitivity, specificity, and rapid turnaround times.
Market Dynamics
The global enzyme immunoassay market is primarily driven by the escalating prevalence of chronic diseases including diabetes, cardiovascular disorders, infectious diseases, and cancer, which necessitate frequent diagnostic monitoring and screening programs across healthcare systems globally. The aging global population, coupled with increasing healthcare awareness and government initiatives promoting preventive healthcare, has significantly boosted demand for reliable diagnostic solutions. Technological advancements in assay development, including the introduction of multiplexed platforms, automated systems, and point-of-care devices, have enhanced testing efficiency and expanded market applications. However, the market faces substantial restraints including stringent regulatory requirements for diagnostic device approvals, which often result in lengthy and costly validation processes that can delay product launches and increase development expenses.
The high cost associated with advanced EIA instruments and the requirement for skilled technical personnel to operate sophisticated systems pose additional barriers, particularly in emerging markets with limited healthcare budgets. Competition from alternative diagnostic technologies such as chemiluminescent immunoassays (CLIA), molecular diagnostics, and rapid antigen tests creates pricing pressures and market share challenges. Nevertheless, significant opportunities exist in expanding applications within emerging markets, where improving healthcare infrastructure and increasing disposable incomes are driving demand for diagnostic services. The growing focus on personalized medicine, companion diagnostics, and biomarker discovery presents new avenues for market growth, while the integration of artificial intelligence and digital health platforms offers potential for enhanced assay performance and data management capabilities.
Key Features of the Study
- This report provides in-depth analysis of the global enzyme immunoassay market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global enzyme immunoassay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, bioMerieux, Beckman Coulter (Danaher), Thermo Fisher Scientific, Bio-Rad Laboratories, Revvity (PerkinElmer), DiaSorin, QuidelOrtho, EUROIMMUN (a Revvity company), Randox Laboratories, Bio-Techne (R&D Systems), Merck KGaA (MilliporeSigma), and Tecan
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global enzyme immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enzyme immunoassay market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Reagents and Kits
- Analyzers/Instruments
- Software and Automation Systems
- Consumables and Accessories
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Enzyme-Linked Fluorescent Assay (ELFA)
- Chemiluminescent Enzyme Immunoassay (CL-EIA)
- Rapid Test Enzyme Immunoassay
- Multiplex Enzyme Immunoassay
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Infectious Disease Diagnostics
- Oncology
- Cardiology
- Autoimmune Diseases
- Endocrinology
- Drug Monitoring and Toxicology
- Allergy Testing
- Others
- Specimen Type Insights (Revenue, USD Bn, 2020 - 2032)
- Blood/Serum
- Urine
- Saliva
- Tissue Samples
- Others (CSF, Plasma)
- Automation Level Insights (Revenue, USD Bn, 2020 - 2032)
- Manual
- Semi-automated
- Fully automated
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and Clinics
- Diagnostic Laboratories
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott
- Roche Diagnostics
- Siemens Healthineers
- bioMerieux
- Beckman Coulter (Danaher)
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Revvity (PerkinElmer)
- DiaSorin
- QuidelOrtho
- EUROIMMUN (a Revvity company)
- Randox Laboratories
- Bio-Techne (R&D Systems)
- Merck KGaA (MilliporeSigma)
- Tecan
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Enzyme Immunoassay Market, By Product Type
- Global Enzyme Immunoassay Market, By Technology
- Global Enzyme Immunoassay Market, By Application
- Global Enzyme Immunoassay Market, By Specimen Type
- Global Enzyme Immunoassay Market, By Automation Level
- Global Enzyme Immunoassay Market, By End User
- Global Enzyme Immunoassay Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Enzyme Immunoassay Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Analyzers/Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Software and Automation Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables and Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Enzyme Immunoassay Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Enzyme-Linked Fluorescent Assay (ELFA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chemiluminescent Enzyme Immunoassay (CL-EIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rapid Test Enzyme Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Multiplex Enzyme Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Enzyme Immunoassay Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Infectious Disease Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug Monitoring and Toxicology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allergy Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Enzyme Immunoassay Market, By Specimen Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Blood/Serum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tissue Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (CSF, Plasma)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Enzyme Immunoassay Market, By Automation Level, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Manual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Semi-automated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fully automated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Enzyme Immunoassay Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Enzyme Immunoassay Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter (Danaher)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revvity (PerkinElmer)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaSorin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EUROIMMUN (a Revvity company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Randox Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne (R&D Systems)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tecan
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
